Anavex Life Sciences Cash Flow | StatInvestor

Health Care & Life Sciences » Biotechnology | Anavex Life Sciences Corp.

Anavex Life Sciences Corp. | Cash Flow

No data

About Anavex Life Sciences

View Profile

Address	51 West 52nd Street New York New York 10019 United States
Employees	-
Website	http://www.anavex.com
Updated	07/08/2019
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.